altimmune glp 1 Altimmune, Inc. Announces Presentation of IMPACT Phase 2b Study Results at EASL Congress 2026, Highlighting Efficacy and Safety Data for Pemvidutide in MASH We're pleased to share results

Obesity is one factor that has "stalled progress in life expectancy," as it is linked to 70% of the leading causes of death in high-income countries, according to the researchers

Get on the Cultural Bandwagon: Expect the influence of GLP-1 users' dietary habits to have an influence far beyond users themselves as these concepts spread to the mainstream M&S is betting that in 2026, the most valuable label on a package won't be "Low Calorie" - but "Nutrient Dense"

Shafer says GLP-1 face is closely tied to fat loss and timing

The good news: With the right support you can feel like yourself again

Biochimica et Biophysica Acta, 1330 (2), 274283